Furthermore, it is evident that obesity can lead to higher levels of pro-inflammatory cytokines, insulin, leptin and sex steroids, which have all been associated with cancer at various anatomic sites [13]; in addition to these potential mechanisms, there may be other metabolic perturbations associated with obesity that affect cancer risk. This evidence concerns the gene INS and obesity due to melanocortin 4 receptor deficiency.